Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 29, 2019

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2024

Conditions

Autoimmune DiseasesPremature Ovarian Insufficiency

Interventions

DRUG

Rituximab

1 gram rituximab twice with two weeks interval

Trial Locations (1)

Angelica Hirshberg, Stockholm

All Listed Sponsors

lead

Angelica Lindén Hirschberg

OTHER

NCT05586737 - Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency | Biotech Hunter | Biotech Hunter